Cliff Asness's ALDX Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 1.23 M shares of Aldeyra Therapeutics, Inc. (ALDX) worth $6.36 M, representing 0.00% of the portfolio. First purchased in 2018-Q4, this medium-term investment has been held for 18 quarters.
Based on 13F filings, Cliff Asness has maintained a strategic position in ALDX, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2025, adding 1.08 M shares. Largest reduction occurred in Q4 2025, reducing 278,438 shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's Aldeyra Therapeutics (ALDX) Holding Value Over Time
Track share changes against reported price movement
Quarterly Aldeyra Therapeutics (ALDX) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -278,438 | Reduce 18.50% | 1.23 M | $5.18 |
| Q3 2025 | +31,548 | Add 2.14% | 1.51 M | $5.22 |
| Q2 2025 | +1.08 M | Add 275.44% | 1.47 M | $3.83 |
| Q1 2025 | +321,992 | Add 456.32% | 392,555 | $5.75 |
| Q4 2024 | +70,563 | New Buy | 70,563 | $4.99 |
| Q3 2024 | -34,781 | Sold Out | 0 | $0.00 |
| Q2 2024 | -70,273 | Reduce 66.89% | 34,781 | $3.31 |
| Q1 2024 | +105,054 | New Buy | 105,054 | $3.27 |
| Q4 2023 | -20,913 | Sold Out | 0 | $0.00 |
| Q3 2023 | -5,245 | Reduce 20.05% | 20,913 | $6.68 |
| Q2 2023 | +26,158 | New Buy | 26,158 | $8.39 |
| Q3 2022 | -40,954 | Sold Out | 0 | $0.00 |
| Q2 2022 | +40,954 | New Buy | 40,954 | $3.98 |
| Q3 2021 | -22,629 | Sold Out | 0 | $0.00 |
| Q2 2021 | +22,629 | New Buy | 22,629 | $11.31 |
| Q2 2019 | -20,145 | Sold Out | 0 | $0.00 |
| Q1 2019 | +7,171 | Add 55.27% | 20,145 | $9.03 |
| Q4 2018 | +12,974 | New Buy | 12,974 | $8.32 |
Cliff Asness's Aldeyra Therapeutics Investment FAQs
Cliff Asness first purchased Aldeyra Therapeutics, Inc. (ALDX) in Q4 2018, acquiring 12,974 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held Aldeyra Therapeutics, Inc. (ALDX) for 18 quarters since Q4 2018.
Cliff Asness's largest addition to Aldeyra Therapeutics, Inc. (ALDX) was in Q2 2025, adding 1,473,812 shares worth $5.64 M.
According to the latest 13F filing for Q4 2025, Cliff Asness's firm, Aqr Capital Management LLC, owns 1,226,922 shares of Aldeyra Therapeutics, Inc. (ALDX), valued at approximately $6.36 M.
As of the Q4 2025 filing, Aldeyra Therapeutics, Inc. (ALDX) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in Aldeyra Therapeutics, Inc. (ALDX) was 1,505,360 shares, as reported at the end of Q3 2025.